3
Total investments
1
Early stage
0
Mid stage
2
Late stage
7y
Years active
Portfolio
3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Series B Investor, Advisor
Dec 2019
MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate.
DISRUPTING TO ADVANCE HEALTHCARE
MobileODT is blazing a path similar to disruptive technologies in other markets:
We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability.
We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes.
And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs.
FIRST FOCUS: CERVICAL CANCER SCREENING
MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.
Series B Investor
Dec 2019
MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate.
DISRUPTING TO ADVANCE HEALTHCARE
MobileODT is blazing a path similar to disruptive technologies in other markets:
We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability.
We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes.
And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs.
FIRST FOCUS: CERVICAL CANCER SCREENING
MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.
Experience · 10 entries
All (10)
Investments (3)
Founder (2)
2025
Managing Director, BioPharma Strategy
Feb 2025
LifeSci Advisors is a unique investor relations consultancy founded to provide companies in the life sciences field with a comprehensive solution to investor communications and outreach. Our services are designed to increase our clients’ visibility within the investment community and to educate investors about the opportunity. We strive to effectively communicate each clients’ unique value proposition, building momentum for the investment. We begin with deep due diligence as we partner with each client to gain an unparalleled level of understanding of their business and the opportunities they are addressing. This in-depth knowledge allows us to be able to provide each client partner with thoughtful recommendations related to corporate communications, investor outreach, and capital markets planning. Our strategies and actions are specifically tailored to help each client achieve their investor relations goals.
2019
Series B Investor, Advisor
Dec 2019
MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate.
DISRUPTING TO ADVANCE HEALTHCARE
MobileODT is blazing a path similar to disruptive technologies in other markets:
We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability.
We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes.
And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs.
FIRST FOCUS: CERVICAL CANCER SCREENING
MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.
Series B Investor
Dec 2019
MobileODT is driven by a mission: to deliver affordable, practical healthcare innovation and make a difference in the world. Now. We do it through the creation of breakthrough optical diagnostic devices and software services focused on early cancer detection and, soon, a range of other medical purposes. We deliver it at a cost that enables rapid uptake and wide utilization everywhere, but particularly in low-resource settings, where the need is most acute and the impact can be immediate.
DISRUPTING TO ADVANCE HEALTHCARE
MobileODT is blazing a path similar to disruptive technologies in other markets:
We leverage the ubiquity and native capability of smartphones to do something that’s never been done before, replacing complex and cost-prohibitive systems with simplicity and affordability.
We create highly advanced optical technology components to turn the smartphone into a mobile, easy-to-use point-of-care tool to help detect cancer and capture a range of biomedical images for diagnostic and other analytical purposes.
And we develop intuitive app-based programs to operate our devices and connect to a cloud-based software platform that enables exciting capabilities that could not be imagined just a few years ago — from immediate remote expert consultations to improved case management and, importantly, to easy integration with the range of emerging electronic health records programs.
FIRST FOCUS: CERVICAL CANCER SCREENING
MobileODT’s technology is a potentially game-changing solution to reduce cervical cancer, a global health priority that requires approximately 700 million screenings per year. Our Cervical Cancer Screening System has met with enthusiastic response in eight pilot markets around the world.
VU Venture Fund (Venture Partner/ Senior health care advisor)
Aug 2019
VU Venture Partners is a multi-stage venture capital fund focusing on Consumer, Enterprise, FinTech, Frontier, Healthcare, and PropTech
Show all 10 entries ↓
